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Abstract 
Sodium arsenite (NA) and cadmium chloride (CdCl2) are two relatively abundant 
environmental toxicants that have numerous detrimental effects on living organisms.  At 
the cellular level, NA and CdCl2 produce reactive oxygen species which cause protein 
damage.  Recent studies, in mammalian systems, have suggested that NA and CdCl2 can 
inhibit the ubiquitin-proteasome system (UPS).  The UPS is the major degradation route 
for the elimination of damaged protein.  This process involves two successive steps: the 
addition of ubiquitin to damaged protein and subsequent degradation by the 26S 
proteasome.  Previously our laboratory determined that inhibition of the UPS can induce 
the accumulation of heat shock protein (HSPs) in Xenopus laevis A6 cells.  HSPs are 
molecular chaperones, which bind to unfolded proteins to prevent aggregation and assist 
in protein refolding.  The goal of this study was to examine the effect of NA and CdCl2 
on the UPS of Xenopus laevis cells and to investigate any possible association between 
HSP accumulation and proteasomal activity.   In the present study, treatment of A6 cells 
with NA or CdCl2 caused an increase in HSP30 and HSP70 accumulation, as well as in 
protein ubiquitination.  In fact, treatment with 30 µM NA or 200 µM CdCl2 resulted in a 
1.7- and 2-fold increase, respectively, in the relative levels of ubiquitinated protein 
compared to control.  Examination of the relative levels of ubiquitinated protein over 
time revealed significant increases in cells treated up to at least 24 h after exposure of A6 
cells with 30 µM NA or 200 µM CdCl2.  To further examine the effect of NA and CdCl2 
on proteasome activity, a cell-based assay measuring proteasomal chymotrypsin (CT)-
like activity was employed.  Treatment with 20 or 30 µM NA caused a 40 % decrease in 
the relative levels of chymotrypsin (CT)-like activity in A6 cells compared to control 
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cells.  The CT-like activity of A6 cells treated with 100 or 200 µM CdCl2 decreased by 
40 % and 75 %, respectively, compared to control.  The increase in ubiquitinated protein 
and a decrease in CT-like activity suggest that NA and CdCl2 can inhibit the UPS in A6 
cells.  In order to examine any possible association between HSP accumulation and 
proteasome activity an inhibitor of HSP accumulation, KNK437, was employed.  In A6 
cells pretreated with KNK437 followed by NA or CdCl2 exposure a decrease in the 
relative levels of HSP30 and HSP70 and ubiquitinated protein was noted compared to 
cells treated with NA alone.  However, the CT-like activity of cells pretreated with 
KNK437 prior to NA or CdCl2 showed no significant difference compared to cells treated 
with NA or CdCl2 without pretreatment.  The findings of this study suggest that NA and 
CdCl2 inhibit proteasomal activity in A6 cells and that there is a possible association 
between HSP accumulation and the mechanism by which damaged proteins are 
ubiquitinated. 
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1. Introduction 
Stress can have adverse effects on organisms, tissues and cells.  At the cellular 
level, stress, both environmental and physiological, can cause protein to unfold, misfold 
and aggregate which can cause a disruption of normal function.  In response to stress, 
cells have protective mechanisms which involve a change in gene expression which 
includes increased transcription of heat shock protein genes (hsp) and proteasomal 
degradation (Morimoto, 2008).   
1.1 Heat Shock Proteins  
Heat shock proteins (HSPs) are a large group of molecular chaperones that were 
first discovered in 1962 by Ritossa in the salivary glands of Drosophila.  HSPs are 
expressed in response to a number of signals such as environmental stressors, non-stress 
conditions, such as growth and development, pathophysiological state and disease states 
(Morimoto, 1998; 2008).  As molecular chaperones, HSPs play an important role in 
regulating protein conformation by binding to unfolded or abnormal proteins maintaining 
them in a folding competent state until normal physiological conditions return and 
refolding can occur (Morimoto, 1998; 2008).  Furthermore, HSPs are involved in 
assembly and disassembly of macromolecular complexes, regulating translocation and 
facilitating posttranslational folding (Morimoto, 2008).  Some HSPs are constitutively 
expressed, while others are inducible.  There are six families of HSPs based on molecular 
size: HSP100, HSP90, HSP70, HSP60, HSP40 and the small HSPs (sHSPs).   
1.2 Heat Shock Protein 70 
HSP70 molecular chaperones are a highly conserved and abundant family 
involved in regulating protein folding during normal and stress conditions (Katschinski, 
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2004).  In eukaryotic cells, the HSP70 family includes cytoplasmic stress-inducible 
HSP70, cytoplasmic constitutively expressed heat shock cognate 70 (HSC70), 
mitochondrial HSP70 and immunoglobulin-binding protein (BiP; also referred to as 
glucose-regulated protein 78 or GRP78), which is found in the endoplasmic reticulum 
(Morimoto, 1998; 2008).  HSP70 proteins have highly conserved amino acid sequences 
and are found in every organism in multiple cellular components (Daugaard et al., 2007).  
The HSP70 domain structures include an ATPase domain, a region with protease 
sensitive sites, a peptide binding domain and C-terminal region that is G/P-rich  
(Daugaard et al., 2007).  The C-terminal region contains an EEVD-motif which enables 
HSP70 to bind other HSPs and co-chaperones and is required for chaperone function 
(Daugaard et al., 2007).  Co-chaperones such as Bag-1, carboxyl terminus of Hsc70-
interacting protein (CHIP), HSP40/DnaJ, HSP70 interacting protein (HIP) and HSP70-
HSP90 organizing protein (HOP) bind to HSP70 to regulate its activity and accomplish 
its diverse functions including the protection of cells from aggregation of unfolded 
protein and assist in the folding or refolding of these proteins (Boorstein et al., 1994; 
Katschinski, 2004).  In addition, HSP70 proteins have been shown to inhibit apoptosis 
and are involved in the degradation of abnormal or misfolded protein, translocation of 
proteins between cellular compartments and protein complex degradation (Mosser et al., 
2000; Katschinski, 2004; Daugaard et al., 2007).  
1.3 Small Heat Shock Proteins 
The sHSPs are a group of molecular chaperones which range in size from 10 to 42 
kDa.  They are a highly divergent family with a conserved α-crystallin domain of 80-100 
amino acids and are found in nearly every cellular compartment in almost every organism 
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(Franck et al., 2004; Nakamoto and Vigh, 2007).  SHSPs are involved in numerous 
cellular processes such as cellular differentiation, chaperone activity, actin 
capping/decapping and modulation of redox perameters (MacRae, 2000; Van Montfort et 
al., 2001).  SHSPs have the ability to aggregate into large, highly polymeric structures 
that are necessary for function within the cell (Arrigo and Landry, 1994; MacRae, 2000; 
Van Montfort et al., 2001; Heikkila, 2004).  
Although the sHSPs are a diverse group of stress proteins, most contain two or 
three functional domains.  The first domain is the previously mentioned α-crystallin 
domain located near the carboxy-terminus.  This domain consists of β–strands organized 
into β–sheets and is responsible for dimer formation (Kim et al., 1998, van Montfort et 
al., 2001).  The amino-terminal is thought to be involved in oligomerization while the 
carboxy-terminal extension stabilizes oligomers and is essential for chaperone function 
(MacRae, 2000; Fernando and Heikkila, 2000).  Studies indicate that the carboxyl region 
is required to inhibit stress-induced aggregation and to maintain secondary structure for 
chaperone function (Fernando and Heikkila, 2000).   
 Most sHSPs assemble into large oligomeric complexes that are between 9 and 30 
subunits in size (Kim et al., 1998; Nakamoto and Vigh, 2007).  These oligomeric 
complexes, and the dissociation of them, are necessary for the chaperone function of 
sHSPs and are important in their regulation (van Montfort et al., 2001; Stromer et al., 
2003; Nakamoto and Vigh, 2007).  As molecular chaperones, sHSP bind with non-native 
proteins, holding them in a folding competent state, in order to prevent their aggregation.  
Once the stress has been removed, sHSPs associate with ATP-dependent HSPs, like 
HSP70, which will assist in refolding the protein (MacRae, 2000).  Phosphorylation 
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removes sHSPs from the complex therefore changing the secondary structure and 
inhibiting oligomerization (Fernando et al., 2003).   
1.4 Heat Shock Response 
The heat shock response, also known as the stress response, is a protective 
mechanism that functions to initiate recovery and adaptation to stress (Morimoto, 2008).  
Regulation of stress-induced hsp gene expression in eukaryotes is controlled primarily at 
the level of transcription by heat shock factor (HSF1).  Evidence of HSF1 involvement in 
HSP accumulation was shown using small interfering RNA (siRNA) to knockdown 
HSF1.  This knockdown caused a decrease in HSP70 and HSP40 accumulation (Song et 
al., 2010).  HSF1 is a member of the family of transcription factors called HSFs, which 
also includes HSF2, HSF3 and HSF4, and specifically binds to heat shock elements 
(HSEs) in the promoters of hsp genes. A single HSF protein is expressed in lower 
eukaryotes such as Drosophila, Caenorhabditis elegans and yeast (Shamovsky & Nudler, 
2008).  Xenopus laevis expresses at least two distinct HSFs, mammalian cells have three 
different HSFs while plants have been shown to possess more than twenty unique HSF 
proteins (Shamovsky & Nudler, 2008).  HSF1 is the stress-responsive member of the 
HSF family and is activated by a number of stressors that cause the accumulation of 
unfolded protein including heat shock, sodium arsenite (NA) and cadmium chloride 
(CdCl2) treatment (Voellmy, 2004; Morimoto, 2008). 
HSF1 is a member of the family of “winged” helix-turn-helix transcription factors 
(Shamovsky & Nudler, 2008).  There is little homology between different species, but the 
domain organization is conserved.  The N-terminal DNA binding domain (DBD) is 
followed by an oligomerization domain, which contains two hydrophobic repeat domains 
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(HR-A/B), and by a regulatory domain.  An additional hydrophobic repeat, HR-C, and a 
transactivation domain are located further downstream (Shamovsky & Nudler, 2008).   
The DBD is the region of HSF1 that interacts with the HSE sequences in the 
promoters of hsp genes (Voellmy, 2004).  The hydrophobic repeats of the 
oligomerization domain and HR-C at the C-terminal are leucine zipper domains.  
Intramolecular interactions of HR-A and HR-B with HR-C maintain HSF1 in a 
monomeric form by suppressing trimerization (necessary for binding to HSE).  Upon 
cellular stress, the intramolecular interactions maintaining HSF1 in its monomeric state 
are disrupted allowing the newly former trimer to bind to the HSE (Rabindran et al., 
1993; Shamovsky and Nudler, 2008).  The regulatory domain is the location for both 
constitutive and inducible serine phosphorylation and regulates the transactivation 
domain which is located at the C-terminal (Pirkkala, 2001).  
As summarized in Figure 1, inactive HSF1 is found in the cytoplasm as a 
monomer bound to HSP90.  Under stressful conditions, HSF1 trimerizes, translocates to 
the nucleus and binds to the HSE in the 5’ promoter region of these genes and facilitates 
transcription of hsp genes by RNA polymerase II (Feige et al., 1996; Voellmy, 2004; 
Heikkila, 2010).  Once these proteins are produced they bind to unfolded and denatured 
proteins and maintain them in a folding competent state until the stress is no longer 
present.  Following the removal of the stressor, the cell stops producing excess HSPs and 
their levels return to pre-stress conditions (Heikkila, 2003).  
The HSE is conserved among all eukaryotes and is composed of multiple inverted 
repeats of the five nucleotide motif nGAAn (Amin et al., 1988, Xiao & Lis, 1988; 
Schuetz et al., 1991).   This motif is considered the fundamental unit of recognition and  
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Figure 1. Stress-induced activation of HSR.  (1) External stressful stimuli cause native 
proteins in the cell to unfold.  (2) HSP90 is bound to HSF1 under normal conditions in 
the cell and upon stress is recruited to prevent aggregation of unfolded proteins.  (3) This 
allows HSF1 monomers to trimerize and translocate to the nucleus.  (4) The HSF1 trimer 
binds to the heat shock element at the 5’ promoter of hsp genes initiating transcription by 
RNA polymerase II.  (5) Stress-induced HSPs are recruited to the unfolded protein to 
maintain it in a folding competent state.  (6) KNK437 inhibits the activation of HSF1.
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each subunit of HSF trimer interacts with one of three nGAAn repeats within the 
complete HSE (Perisic et al., 1989).  At least one HSE is present within all promoters of 
stress-inducible hsp genes, mediating the response to heat shock as well as other 
stressors, such as agents that alter protein conformation (Mosser et al., 1990; Shamovsky 
and Nudler, 2008). 
KNK437 (N-formyl-3,4-methylenedioxy-benzylidene-γ-butyrolactam) is a 
benzylidene lactam compound that has been used to inhibit HSP accumulation (Yokota et 
al., 2000).  Ohnishi et al. (2004) determined that KNK437 suppresses binding of HSF1 to 
the HSE which is required for hsp gene expression.  The effects of KNK437 on HSP 
accumulation are similar to results found in studies employing siRNA for HSF1.  For 
example, Song et al. (2010) showed a similar decrease in HSP70 and HSP40 
accumulation when either KNK437 or HSF1-siRNA was used.  In previous studies, our 
laboratory has shown that in Xenopus laevis A6 cells, KNK437 inhibits hsp gene 
expression induced by heat shock, NA, CdCl2, herbimycin A, MG132, celastrol and 
curcumin (Manwell and Heikkila, 2007; Voyer and Heikkila, 2008; Walcott and 
Heikkila, 2010; Khan and Heikkila, 2011).  The inhibition of HSP accumulation by 
KNK437 was also shown in human cells, as was a suppression of the acquisition of 
thermotolerance in cells (Yokota et al., 2000; Ohnishi et al., 2004) 
1.5 Xenopus laevis 
The South African clawed frog, Xenopus laevis, is an entirely aquatic organism 
that has been used in developmental research for numerous years.  A great deal of 
information on eukaryotic cell biology and the regulation of gene expression has been 
obtained from this system.  Furthermore, Xenopus cultured cells are available as 
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amphibian model systems including the A6 kidney epithelial cell line which was 
developed by Rafferty in 1969.  This continuous cell line is easy to culture and has quick 
cell generation and growth.  It has been used for numerous studies including examination 
of proliferation, differentiation and signal transduction pathways, and the regulation of 
epithelial sodium channels, to name a few (Matsumoto et al., 1993; Tanaka et al., 2003; 
Guerra et al., 2004; Bjerregaard, 2007; Yu et al., 2008).  
1.5.1 Xenopus HSP70 
 Bienz (1984) first isolated 4 members of the stress-inducible hsp70 gene family.  
In Xenopus four hsp70 genes have been isolated (A-D), however the full gene for hsp70A 
is the only complete sequence available. Additionally, our laboratory has isolated and 
characterized the constitutively expressed hsc70.I and hsc70.II genes and BiP gene (Ali et 
al., 1996a; 1996b; Miskovic et al., 1997). The hsp70 genes are intronless and in the 5’ 
region there are cis-acting elements which include a TATA and CCAAT box and 3 HSEs 
(Heikkila, 2010).   Hsp70 gene expression was induced in A6 cells by a variety of 
stressors such as heat shock, herbimycin A, hydrogen peroxide, NA, CdCl2, celastrol and 
curcumin (Darasch et al., 1988; Briant et al., 1997; Muller et al, 2004; Woolfson and 
Hekkila, 2009; Young et al., 2009; Walcott and Heikkila, 2010; Khan and Heikkila, 
2011).  
1.5.2 Xenopus HSP30 
HSP30 is a member of the sHSP family that has been extensively examined in 
Xenopus laevis.  To date, five isoforms of the Xenopus HSP30 genes have been isolated, 
hsp30A-E.  Of these isoforms, hsp30A and hsp30B were found to be non-functional, due 
to an insertional mutation in the coding region of hsp30A while hsp30B was a 
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pseudogene (Bienz, 1984).  Hsp30C and hsp30D encoded fully functional 24 kDa 
proteins that can act as molecular chaperones and contain the conserved α-crystallin 
domain found in other sHSPs (Krone et al., 1992).  Hsp30E was only partially sequenced.  
Hsp30 genes lack introns and have an AT rich 3’ end which contains a mRNA instability 
sequence and a polyadenylation sequence (Krone et al., 1992).  Analysis of the 5’ region 
of the hsp30C gene revealed multiple cis-acting elements: a CCAAT box, 2 TATA boxes 
and 3 HSEs (Krone et al., 1992).  Various cellular stresses including heat shock, NA, 
herbimycin A, hydrogen peroxide, CdCl2, celastrol and curcumin were shown to induce 
hsp30 gene expression in Xenopus laevis cultured cells (Briant et al., 1997; Muller et al., 
2004; Young et al., 2009; Woolfson and Heikkila, 2009; Walcott and Heikkila, 2010; 
Khan and Heikkila, 2011).  The intracellular localization of HSP30 in Xenopus A6 cells, 
as determined by immunocytochemistry, was found to be primarily in the cytoplasm in a 
granular pattern (Gellalchew and Heikkila, 2005).  Additionally, HSP30 displays 
molecular chaperone activity by preventing heat-induced aggregation of proteins and 
maintaining them in a folding competent state (Fernando and Heikkila, 2000; Abdulle et 
al., 2002). 
1.6 Ubiquitin Proteasome System  
 The ubiquitin proteasome system (UPS) is the major degradation route for the 
elimination of cellular proteins.  This process is important in maintaining homeostasis 
during a number of biological processes such as cell cycle progression, development and 
differentiation, as well as eliminating damaged or misfolded proteins.  The UPS is 
responsible for 80-90% of cellular degradation (Lee and Goldberg, 1998).  Degradation 
of cellular proteins by the UPS is an ATP-dependent process which involves two 
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successive steps: the addition of ubiquitin to proteins targeted for degradation and 
subsequent degradation by the 26S proteasome.   
Ubiquitination involves multiple ubiquitinating enzymes denoted E1 thru E4.  
Initially, ubiquitin activating enzymes (E1) activate ubiquitin in an ATP-dependent 
process which involves adenylation of ubiquitin (Lehman, 2009).  Once activated, 
ubiquitin is transferred to a cysteine residue on a ubiquitin conjugating enzyme (E2).  The 
E2 bound ubiquitin is subsequently transferred to an ubiquitin ligase (E3), which is 
capable of recognizing proteins targeted for degradation.  E3 enzymes bind ubiquitin to 
the target protein by creating an isopeptide bond between the carboxy-terminal glycine of 
ubiquitin and a lysine residue of the protein (Lehman, 2009).  For recognition of target 
damaged proteins by the 26S proteasome a minimum of four ubiquitin molecules are 
required.  A fourth ubiquitin enzyme (E4) has been shown to facilitate the conjugation of 
additional ubiquitin molecules to create a polyubiquitin chain.   
The 26S proteasome is responsible for enzymatic degradation of 
polyubiquitinated proteins.  Structurally, it consists of a 20S core surrounded by two 19S 
regulatory particles on either end.  The 19S regulatory regions recognize ubiquitinated 
protein and in the presence of ATP pass the protein to the 20S core (Lee and Goldberg, 
1998).  The 19S particles contain deubiquitinating enzymes that release free ubiquitin as 
damaged proteins enter the 26S proteasome (Lee and Goldberg, 1998).  The 20S core is 
made up of four α or β heptameric stacked rings in an αββα conformation.  The α 
subunits surround a small opening for entrance of polypeptide substrates, whereas β 
subunits contain proteolytic sites that function together in protein degradation (Lee and 
Goldberg, 1998).  The β-rings in eukaryotes have catalytic sites with chymotrypsin-like, 
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trypsin-like and caspase-like activity (Lee and Goldberg, 1998).  Exopeptidases break 
down most peptide products into amino acids, but some products are transported to the 
cell surface for antigen presentation after binding to major histocompatibilty complex 
(MHC) class I molecules in the endoplasmic reticulum (Bogyo et al., 1997; Lee and 
Goldberg, 1998). 
A schematic summary of the UPS can be found in Figure 2.  Proteins destined for 
degradation are tagged with ubiquitin by the ubiquitinating enzymes.  These tagged 
proteins are recognized by the 19S regulatory subunits of the 26S proteasome which pass 
the damaged protein to the 20S core, releasing ubiquitin, for enzymatic degradation.  The 
tagged proteins are broken down into peptides by the catalytic sites in the 20S core.   
1.6.1 Proteasomal Inhibition 
Inhibition of the proteasome can have a number of effects on cells including a 
decrease in the rate of protein breakdown and disruption of normal levels of proteolysis. 
Along with the accumulation of regulatory proteins, such as the cyclin-dependent kinases 
p21 and p27, proteasome inhibition can lead to aggregation of damaged protein and 
apoptosis (Yang et al., 2008).  Numerous disease states, such as Alzheimer’s, 
Huntington’s and Parkinson’s disease, have been associated with the impairment of the 
UPS (Masliah et al., 2000; Ross and Pickart, 2004).  In Xenopus and other eukaryotic 
organisms, inhibition of the proteasome has also been associated with an increase in hsp 
gene expression (Bush et al., 1997; Stangl et al., 2002; Pritts et al., 2002; Le Goff et al., 
2004; Awasthi and Wagner, 2005; Lundgren et al., 2005; Noonan et al., 2007; Young and 
Heikkila, 2010; Walcott and Heikkila, 2010; Khan and Heikkila, 2011).  There are 
several chemical inhibitors of proteasome activity such as carbobenzoxy-L-leucyl-L-  









Figure 2.  Schematic diagram of cellular protein degradation by the UPS.  
Polypeptides that are destined for degradation are tagged by the addition of ubiquitin 
molecules by the ubiquitinating enzymes in the presence of ATP.  Polyubiquitinated 
proteins are recognized by the 19S regulatory particle of the 26S proteasome.  These 
proteins are degraded within the 20S core resulting in small peptides.  Some of these 
peptides are further degraded into amino acids, while others are transported to the cell 
surface for antigen presentation (Adapted from Lee and Goldberg, 1998). 
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leucyl-L-leucinal (MG132), lactacystin, celastrol and curcumin which have been shown 
to inhibit proteasome activity and induce hsp gene expression in Xenopus A6 cells 
(Young and Heikkila, 2010; Walcott and Heikkila, 2010; Khan and Heikkila, 2011). 
1.6.2 CHIP: an E3 ubiquitin ligase  
An interaction between molecular chaperones and E3 ubiquitin ligases has been 
suggested in the process of ubiquitination.  The main substrate recognition factor of the  
carboxyl terminus of Hsc70-interacting protein (CHIP), an E3 ubiquitin ligase, has been 
suggested to be HSP70 (Esser et al., 2004).  CHIP can bind HSP70 or HSC70 through its 
N-terminal tetratricopeptide domain and it contains a U-box domain at the C-terminal 
that binds to E2 conjugating enzymes (Esser et al., 2004).  A number of studies have 
suggested that CHIP preferentially ubiquitinates HSP70-bound substrates (Meacham et 
al., 2001; Murata et al., 2001; Peng et al., 2004). 
1.6.3 Folding versus degradation 
 The fate of HSP70 bound substrates is determined by the interaction of HSP70 
with various cofactors.  An intracellular competition occurs for the binding sites of 
HSP70 which determines whether the substrate undergoes degradation or refolding.  
Cofactors such as HIP and HOP promote protein folding whereas an interaction with 
CHIP and Bag-1 leads to degradation of the polypeptide.  CHIP and HOP bind the same 
site of HSP70 at the carboxy-terminus of HSP70, whereas Bag-1 and HIP compete for 
binding at the amino-terminal (Hohfeld and Jentsch, 1997; Scheufler et al., 2000; 
Stankiewicz et al., 2010). 
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1.7 Arsenic 
 Arsenic is an abundant environmental stressor and exposure is commonly due to 
contaminated drinking water and industrial emissions (Del Razo et al., 2001).  It 
primarily accumulates in water and soil (Del Razo et al., 2001).  Arsenic exposure can 
lead to various renal, cardiovascular and hepatic diseases and has been associated with a 
number of cancers affecting major organs such as the liver, lungs, kidneys, bladder and 
skin (Del Razo et al., 2001).  At the cellular level, arsenic can cause metabolic 
abnormalities, inhibition of growth, cytoskeletal collapse and apoptosis (Chou, 1989; Liu 
et al., 2001; Bode and Dong, 2002; Del Razo et al., 2001).   
Toxicity of arsenic depends on the oxidation state and composition and it has 
been shown that inorganic arsenicals, specifically trivalent inorganic arsenic species, such 
as NA, are the most toxic forms (Del Razo et al., 2001).   It has been suggested that 
arsenic causes toxicity by substituting for phosphate which affects processes such as 
DNA synthesis and the synthesis of ATP (Del Razo et al., 2001).  Also, the high affinity 
of arsenite for sulfhydryl groups in protein was also reported as a mechanism of arsenic 
toxicity (Chen et al., 1998; Liu et al., 2001; Del Razo et al., 2001).  Indirect toxicity by 
arsenic compounds is the production of reactive oxygen species and free radicals which 
can induce oxidative damage of cellular proteins (Del Razo et al., 2001).   
Previously in our laboratory it has been shown that NA induces hsp gene 
expression (Ohan et al., 1998; Gauley and Heikkila, 2006; Young et al., 2009).  The 
effect of NA on the UPS has been examined primarily in mammalian systems.  It was 
shown that NA inhibits proteasomal activity as determined by an increase in the relative 
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levels of ubiquitinated protein and decreases in the chymotrypsin-like activity compared 
to control cells (Tsou et al., 2005; Medina-Diaz et al., 2009; Kirkpatrick, 2003).   
1.8 Cadmium  
 Cadmium is a toxic heavy metal that accumulates primarily in the kidney, 
reproductive tissues and liver (Barbier et al., 2004; Mouchet et al., 2006).  Cadmium has 
been associated with a number of cancers such as lung, prostate, kidney and pancreas 
(Waisberg et al., 2003). At the cellular level, cadmium toxicity causes dysregulation of 
gene expression, DNA damage, inhibition of DNA repair, apoptosis and oxidative stress 
(Waisberg et al., 2003; Mouchet et al., 2007; Mendez-Arementa and Rios, 2007; 
Blechinger et al., 2007).  Within cells, cadmium reacts with thiol groups or substitutes for 
zinc in proteins which results in the formation of denatured or abnormal proteins 
(Waisberg et al., 2003; Galazyn-Sidorczuk et al., 2009). 
 In Xenopus A6 cells, CdCl2 was shown to induce HSP30 and HSP70 
accumulation (Woolfson and Heikkila, 2009).  The effect of CdCl2 on proteasome 
activity has primarily been examined in mammalian cells with the exception of studies 
examining marine bivalves, mussels and claims employing mussel gill and digestive 
glands (Thevenod and Friedmann, 1999; Figueiredo-Pereira and Cohen, 1999; 
Othumpangat et al., 2005; McDonagh and Sheehan, 2006; Chora et al., 2008; Li et al., 
2008; Yu et al., 2008; McDonagh, 2009; Yu et al., 2011). 
1.9 Objectives 
 The main goal of this thesis was to examine the effects of NA and CdCl2, on 
proteasome activity and HSP accumulation in Xenopus laevis A6 kidney epithelial cells.  
Furthermore, this study investigated the possibility of an association between HSP 
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accumulation and proteasome activity.  While a large amount of information regarding 
the effects of NA and CdCl2 on proteasome activity in mammals, there is no available 
data in amphibians.  NA and CdCl2 are abundant environmental stressors that cause 
numerous effects on organisms.  Xenopus is an ideal organism to examine the effects of 
environmental contamination due to the fluctuating conditions it experiences in an 
entirely aquatic environment. The specific objectives of this research are as follows: 
• To determine the pattern of HSP30 and HSP70 accumulation in cells exposed to 
various treatment times and concentrations of NA and CdCl2. 
• To determine the effect of NA and CdCl2 on the intracellular localization of 
HSP30 by immunocytochemistry and laser scanning confocal microscopy.   
• To examine the effect of NA and CdCl2 on proteasome activity in A6 cells by 
analyzing the relative level of ubiquitinated protein and chymotrypsin-like 
activity. 
• To determine the effect of the inhibition of NA- and CdCl2-induced HSP30 and 
HSP70 accumulation on proteasome activity by employing KNK437, an inhibitor 
of HSP accumulation. 	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2. Materials and Methods  
2.1 Maintenance and Treatment of A6 Cells 
Xenopus laevis A6 kidney epithelial cells were acquired from the American Type 
Culture Collection (CCL-102) (ATCC, Rockville, MD).  A6 cells were cultured at 22 °C 
in 55% Leibovitz (L)-15 media (Sigma, Oakville, ON) supplemented with 1% 
penicillin/streptomycin (100 U/mL and 100 µg/mL, respectively; Sigma) and 10% fetal 
bovine serum (FBS: Sigma) in T75 cm2 BD Falcon tissue culture flasks (VWR 
International, Mississauga, ON).  Once the cells became confluent, old media was 
removed by aspiration and 2 mL versene [0.02% (w/v) KCl, (0.8% (w/v) NaCl, 0.02% 
(w/v) KH2PO4, 0.115% (w/v) Na2HPO4, 0.02% (w/v) Na2EDTA] was added for 2 min 
and then aspirated.  A second rinse with 1 mL of versene for one minute followed and 
then aspirated.  Subsequently, 1 mL of 1X trypsin (Sigma) in 100% Hank’s balanced salt 
solution (HBSS; Sigma) for 1 min was used to remove cells from the surface of the flask.  
Cells were then resuspended in fresh media and distributed evenly into additional culture 
flasks.   
Flasks that reached approximately 90-100% confluency were used for treatments.  
Heat shock treatments were performed in water baths set at 33 °C or 35 °C for 2 h 
followed by a 2 h recovery at 22 °C.  NA (Sigma) was dissolved in distilled sterile water 
to make a stock solution of 100 mM and this stock solution was used to create a working 
solution of 1 mM concentration.  CdCl2 (Sigma) treatments were performed using a 100 
mM working solution.  MG132 (Sigma) and KNK437 (Calbiochem; Gibbstown, NJ) 
were dissolved in dimethylsulphoxide (Sigma) to prepare 5 mg/mL stock solutions.  
Working solutions of NA and CdCl2 were used to create dilutions of 20 or 30 µM NA or 
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100 or 200 µM CdCl2.   Treatments with MG132 and KNK437 employed concentrations 
of 30 µM MG132 and 100 µM KNK437.  To create these dilutions, the appropriate 
volumes of each chemical were added to 10 mL L-15 media.  Treatments with KNK437 
were performed 2 h prior to treatment with NA or CdCl2.  After the various treatments, 
media was removed from flasks and cells were rinsed with 2 mL of 65% HBSS and then 
1 mL of HBSS was added.  A cell scraper was used to remove cells from the flask which 
were subsequently transferred to a 1.5 mL microcentrifuge tube.  Cells were pelleted by 
centrifugation at 14, 000 rpm for 1 min, the supernatant was removed and cells were 
stored at -80 ˚C until protein isolation. 
2.2 Protein Isolation and Quantification 
Total protein was isolated by resuspending cells with 200 - 400 µL lysis buffer 
(200 mM sucrose, 2 mM EGTA, 1 mM EDTA, 40 mM NaCl, 30 mM HEPES, pH 7.4) 
containing 1 % (w/v) SDS, 1 % (w/v) protease inhibitor cocktail (Roche; Laval, QC).  
For ubiquitinated protein detection 10 mM N-ethylmaleimide (Sigma) was added to the 
lysis buffer to inhibit ubiquitin conjugating enzymes.  A sonic dismembranator (Model 
100, Fisher Scientific; Waltham, MA) was used to sonicate samples on ice for 20 bursts 
followed by centrifugation at 14,000 rpm for 1 h at 4 °C.  The supernatant was 
transferred to a new 1.5 mL microcentrifuge tube and stored at -20 ˚C until use.  
The bicinchoninic acid (BCA) method was used for protein quantification 
according to the manufacturer’s instructions (Pierce, Rockford, IL).  A protein standard 
was created using a bovine serum albumin (BSA; Bioshop; Burlington, ON).  BSA was 
diluted in distilled water to concentrations ranging from 0 to 2 mg/mL.  Protein samples 
were diluted to a concentration of 1:2 in distilled water.  BSA standards and protein 
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samples in 10 µL volumes were loaded into each well, in triplicate, into a 96 well 
polystyrene plate.  To each standard and protein sample 80 µL of BCA reagent A and B 
(Pierce), 50:1, was added and the plate was incubated at 37 °C for 30 minutes.  
Subsequently, the plate was read at 562 nm using a Versamax Tunable microplate reader 
(Molecular Devices, Sunnyvale, California) and Softmax Pro software.  A standard curve 
was created using the BSA protein standards which was used to determine the 
concentration of the protein samples.  
2.3 Western Blot Analysis 
Proteins were separated by SDS-PAGE using 12% gels for HSP30, HSP70 and 
actin and 10% gels for ubiquitinated protein.  Separating gels [10-12% (w/v) acrylamide, 
0.32% (v/v) n’n’-bis methylene acrylamide, 0.375 M Tris pH 8.8, 1% (w/v) SDS, 0.2% 
(w/v) ammonium persulfate (APS), 0.14% (v/v) tetramethylethylenediamine (TEMED)] 
were prepared and left for 20 min to polymerize after 100% ethanol was layered over the 
gel.  Once the separating gel solidified, ethanol was poured off and the stacking gel [4% 
(v/v) acrylamide, 0.11% (v/v) n’n’-bis methylene acrylamide, 0.125 M Tris pH 6.8, 1% 
(w/v) SDS, 0.4% (w/v) APS, 0.21% (v/v) TEMED] was added.  Combs were inserted to 
create lanes and the gel was left to polymerize for 20 min.  As gels polymerized, protein 
samples were prepared using 20 or 60 µg of protein, depending on the primary antibody 
used, and added to loading buffer [0.0625 M Tris pH 6.8, 10% (v/v) glycerol, 2% (w/v) 
SDS, 5% (v/v) β-mercaptoethanol, 0.00125% (w/v) bromophenol blue].  Samples were 
boiled for 10 minutes, cooled, pulse spun and loaded in the gel.  Gels were 
electrophoresed with 1 X running buffer [25 mM Tris, 0.2 M glycine, 1 mM SDS] at 90 
V until samples reached the separating buffer at which point the voltage was increased to 
	   	  22	  
130 V for ubiquitinated protein or 160 V for HSP30, HSP70 and actin until the samples 
reached the bottom of the gel.  As the gel was running, nitrocellulose membranes 
(BioRad, Mississauga, ON) and filter paper (BioRad) were cut to a size of 5 X 8.5 cm.  
Membranes were soaked for 30 min in 10% transfer buffer [25 mM Tris, 192 mM 
glycine, 10% (v/v) methanol], for ubiquitin blots, or 20% transfer buffer [25 mM Tris, 
192 mM glycine, 20% (v/v) methanol], for HSP30, HSP70 and actin.  Once 
electrophoresis was finished, the stacking gel was removed and the remainder of the gel 
was soaked in transfer buffer for 15 min.  Protein was transferred to the nitrocellulose 
membrane with a Trans-Blot Semi-dry Transfer cell (BioRad) for 25 min at 20 V.  Once 
the transfer was complete, membranes were stained with Ponceau-S stain [0.19% (w/v) 
Ponceau-S, 5% (v/v) acetic acid] for 15 min to determine the success of the transfer.  
Blots were rinsed with milliQ water and scanned.  Membranes were then incubated with 
5% blocking [20 mM Tris pH 7.5, 0.1% Tween 20 (Sigma), 300 mM NaCl, 5% (w/v) 
Nestle® Carnation skim milk powder] solution for 1 h to prevent non-specific binding.  
Once the blocking solution was removed, the membranes were incubated with rabbit anti-
Xenopus HSP30 (1:1000), rabbit anti-Xenopus HSP70 (1:350; Abgent, San Diego, CA) or 
rabbit anti-actin (1:200; Sigma) polyclonal antibodies diluted in 5% blocking solution for 
at least 1 h.  For ubiquitinated protein, membranes were incubated overnight with a 
mouse anti-ubiquitin (1:150; Invitrogen, Carlsbad, CA) monoclonal antibody diluted in 
5% bovine serum albumin (BSA; Fisher Scientific).  After incubation with primary 
antibody, membranes were washed three times, once for 15 minutes and twice for ten 
minutes, with 1X TBS-T [20mM Tris, 300 mM NaCl, (pH 7.5), 0.1% (v/v) Tween 20].    
Membranes were then incubated with secondary antibody in blocking solution for 1 h.  
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AP-conjugated goat-anti-rabbit (BioRad) at a dilution of 1:3000 dilution for HSP30, 
HSP70, actin and AP-conjugated goat-anti-mouse (BioRad) at a 1:1000 dilution were 
used.   Following incubation with secondary antibody, TBS-T was used to wash the 
membranes, once for 15 minutes and twice for 5 minutes.  Blots were then immersed in 
alkaline phosphatase detection buffer [50 mM Tris, 50 mM NaCl, 25 mM MgCl2 pH 9.5, 
0.3% 4-nitro blue tetrazolium (NBT; Roche) and 0.17% 5-bromo-4-chloro-3-indolyl 
phosphate, toluidine salt (BCIP; Roche)] until bands or ubiquitinated protein lanes were 
visible and then detection buffer was removed and the blots were rinsed with distilled 
water.  The blots were then scanned.  
2.4 Densitometry and Statistical Analysis 
 Image J software (Version 1.44; National Institute of Health) was used to perform 
densitometric analysis on all blots performed in triplicate.  The average densitometric 
values were expressed and graphed as a percentage of the maximum HSP30 or HSP70 
bands, lane of ubiquitinated protein or as a percentage of treatment without pretreatment 
with KNK437.  The standard error is represented by vertical error bars.  To determine if 
any statistically significant differences existed between samples, a one-way ANOVA 
with a Tukey’s post-test were performed on the data.  Confidence levels used were 95% 
(p<0.05;*) and 85% (p<0.15; ∇). 
2.5 Laser Scanning Confocal Microscopy 
A6 cells were grown on flame sterilized 22 x 22 mm base-washed glass coverslips 
in sterile Petri dishes.  Coverslips were washed with base solution [49.5% (v/v) ethanol, 
0.22 M NaOH] in small staining jars (Thomas Scientific Apparatus, Philadelphia, PA) for 
30 min and then rinsed with distilled water for 3 h.   
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After treatment, L-15 media was removed and cells were rinsed twice with 
phosphate buffered saline (PBS; 1.37 M NaCl, 67 mM Na2HPO4, 26 mM KCl, 14.7 mM 
H2PO4, 1 mM CaCl2, 0.5 mM MgCl2 pH 7.4).  Once washed, coverslips were transferred 
to small Petri dishes and fixed with 3.7 % paraformaldehyde (BDH, Toronto, ON) for 15 
min.  A6 cells were rinsed with three 5 min each washes with PBS and then 
permeabilized using 0.3 % Triton X-100 (Sigma) for 10 min.   After an additional three 
washes with PBS, A6 cells were incubated with 3.7 % (w/v) bovine serum albumin 
fraction V (BSA fraction V; Fischer Scientific) for 1 h or overnight at 4 °C.  
Subsequently, coverslips were incubated with affinity-purified rabbit anti-Xenopus 
HSP30 antibody (1:500) in 3.7 % BSA for 1 h.  After three washes for 3 min each with 
PBS, indirect labeling of cells was carried out with a fluorescent-conjugated secondary 
antibody, goat anti-rabbit Alexa Fluor 488 (Invitrogen Molecular Probes) at a 1:200 
dilution in 3.7 % BSA for 30 min in the dark.  Coverslips were then incubated with 
rhodamine-tetramethylrhodamine-5-isothiocyanate phalloidin (TRITC; Invitrogen 
Molecular Probes) for 15 min at a 1:60 in 3.7 % BSA in the dark in order to visualize the 
actin cytoskeleton.  Coverslips were dried and mounted on a glass microscope slide with 
Vectashield (Vector Laboratories Inc., Burlingame, CA) containing 4,6-diamidino-2-
phenylindole (DAPI; Vector Laboratories Inc.) to stain nuclei followed by three washes 
of 5 min each.  Clear nail polish was used to permanently attach coverslips to glass slides 
and the slides were stored at 4 °C.  Slides were examined using a Zeiss Axiovert 200 
confocal microscope with LSM 510 META software (Carl Zeiss Canada Ltd., 
Mississauga, ON). 
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2.6 Proteasome Assay 
  To examine the chymotrypsin (CT)-like activity of A6 cells treated with NA and 
CdCl2, the Promega Proteasome-Glo Chymotrypsin-like cell based luminescent assay 
kit was used (Promega, Madison, WI).  The Proteasome-Glo Cell-Based Regeant 
contains a specific luminogenic substrate for CT-like activity, Suc-Leu-Leu-Val-Tyr-
aminoluciferin (Suc-LLVY-aminoluciferin) in a buffer for cell permeabilization, 
proteasome activity and luciferase activity. Cleavage of the proteasome generates an 
aminoluciferin substrate that is consumed by luciferase to produce a luminescent signal 
which is proportional to CT-like activity.  To detect the CT-like activity, the Proteasome-
Glo Reagent was produced by equilibrating the Proteasome-Glo Cell-Based Buffer 
and Luciferin Detection Reagent to room temperature and mixing them with the 
flurogenic substrate Suc-LLVY-AMC.   
A6 cells were treated with NA or CdCl2 and following treatment old media was 
removed and flasks were washed with 2 mL of versene and then aspirated.  A second 
rinse with 1 mL of versene for one minute followed and then aspirated.  Cells were then 
detached from flasks using 1 X trypsin and resuspended in 9 mL of L-15 media.  The cell 
suspension was then transferred to a 15 mL falcon tube and centrifuged at 5000 rpm for 3 
min at 4 °C.  Media was removed and pellets were rinsed with 5 mL of fresh L-15 media.  
Again, media was removed and 5 mL of fresh L-15 was added to resuspend A6 cells.  
The total number of cells per mL was determined for each sample using a Bright-Line 
haemocytometer (Hausser Scientific, Horsham, PA) and aliquots of each sample were 
prepared to 15 000 cells per 100 µL of L-15 media.  Each aliquot was added to a white-
walled 96 well plate including a L-15 blank (L-15 media + Proteasome-Glo™ Reagent). 
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Proteasome-Glo™ Reagent was added to each sample in the plate at a 1:1 ratio (100 µL 
reagent).  The plates were mixed for 2 min on a shaker and then incubated at room 
temperature in the dark for 30 min before detection of luminescence.  The Victor3 
luminometer (PerkinElmer Inc., Waltham, MA) was used to detect luminescence of each 
sample with a filter set at 340/480 nm.  Measurements were repeated 5 times and the 
values were compared to the L-15 blank and to control cells maintained at 22 °C.  
	   	  27	  
3. RESULTS 
3.1 Effect of NA and CdCl2 on HSP accumulation 
Previously in our laboratory and in the present study it was shown that a mild heat 
shock or treatment with NA or CdCl2 induced HSP30 and HSP70 accumulation in A6 
cells (Ohan et al., 1998; Phang et al., 1999; Fernando and Heikkila, 2000; Gellalchew and 
Heikkila, 2004; Young et al., 2009; Woolfson and Heikkila, 2009).  For example, cells 
incubated at 33 and 35 °C for 2 h with a 2 h recovery at 22 °C produced an increase in the 
relative levels of HSP30 and HSP70 in comparison to control (Fig. 3).  The multiple 
HSP30 bands found in Figure 3 (top panel) may represent the various family members 
that were detected by the anti-HSP30 antibody which was prepared against the entire 
coding sequence of HSP30C (Fernando and Heikkila, 2000).  This was expected given 
the high amino acid sequence identity among the HSP30 family members (Krone et al., 
1992).  In these experiments, actin levels were relatively unaffected by the heat shock 
treatments.  The effect of two different concentrations of NA is shown in Figure 4.  
Treatment with 20 and 30 µM NA for 16 h caused an increase in HSP30 and HSP70 
accumulation in A6 cells.  Densitometric analysis revealed an enhanced accumulation of 
HSP30 after treatment with 30 µM NA.  The relative levels of HSP70 increased 10-fold 
with 20 µM NA and 7-fold after treatment with 30 µM NA.  Similarly, A6 cells treated 
with 100 or 200 µM CdCl2 for 18 h had elevated levels of HSP30 and HSP70 as shown in 
Figure 5.  Maximal accumulation of HSP30 and HSP70 was detected in cells treated with 
200 µM CdCl2 for 18 h. 
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Figure 3. Heat shock-induced HSP30 and HSP70 accumulation in A6 cells. A6 cells were 
incubated at 33 °C and 35 °C for 2 h with a 2 h recovery at 22 °C.  After treatment cells 
were harvested and total protein was isolated and subjected to immunoblot analysis 
employing a polyclonal rabbit anti-Xenopus HSP30, anti-Xenopus HSP70 or polyclonal 
rabbit anti-actin antibodies as described in the Materials and methods.  The anti-HSP30 
antibody detects multiple family members of the HSP30 family.  These data are 
representative of three separate experiments. 
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Figure 4. NA-induced HSP30 and HSP70 accumulation in A6 cells.  A) Cells were 
maintained at 22 °C (C) or exposed to 20 or 30 µM NA for 16 h at 22 °C.  After 
treatment cells were harvested and total protein was isolated and subjected to immunoblot 
analysis. B) Image J (Version 1.44) software was used to carry out densitometric analysis 
of HSP30 (black bars) and HSP70 (white bars) bands in the western blot images as 
described in Materials and methods.  Results are expressed as a percentage of the 
maximum signal acquired for each protein.  Vertical error bars represent the standard 
error.  The level of significance of the differences between samples was calculated by 
one-way ANOVA with a Tukey’s post-test.  Significant differences between control and 
20 or 30 µM NA are indicated as * (p<0.05).  These results are representative of at least 
three different experiments. 
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Figure 5. The effect of CdCl2 on the accumulation of HSP30 and HSP70 in A6 cells.  A) 
Cells were maintained at 22 °C (C) or treated with CdCl2 concentrations of 100 or 200 
µM for 18 h. After treatment cells were harvested and total protein was isolated and 
subjected to immunoblot analysis.  B) Densitometric analysis of the signal intensity for 
HSP30 (black) and HSP70 (white) protein of the immunoblots was performed using 
Image J software.  The results are expressed as a percentage of the maximum band while 
the standard error is represented by vertical error bars.  One-way ANOVA with a Tukey’s 
post-test was used to calculate the level of significance of the differences between 
samples.  Significant differences between control (C) and cells exposed to CdCl2 for 18 h 
are indicated as * (p<0.05).  These data are representative of three separate experiments. 
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3.2 Localization of HSP30 in NA and CdCl2 treated A6 cells 
The accumulation and intracellular localization of HSP30 induced by NA or 
CdCl2 treatment was verified by immunocytochemistry and laser scanning confocal 
microscopy (LSCM).  The localization of HSP70 was not investigated since the anti-
HSP70 antibody, which was used successfully in immunoblot experiments, was unable to 
specifically detect HSP70 by immunocytochemistry.  As shown in Figures 6 and 7, 
accumulation of HSP30 was not detected in control cells maintained at 22 °C. However, 
treatment with 20 and 30 µM NA for 16 h resulted in the accumulation of HSP30 in 
approximately 90% and 95% of cells, respectively (Fig. 6).  Furthermore, in A6 cells 
treated with 100 and 200 µM CdCl2, HSP30 accumulated in approximately 60% and 95% 
of cells, respectively (Fig. 7).  After both stressors HSP30 was detected primarily in the 
cytoplasm in a granular pattern.  Examination of the actin cytoskeleton revealed that 
treatment with 30 µM NA and 200 µM CdCl2 resulted in the presence of relatively large 
dense actin structures and a loss of the actin stress fibres pattern that was observed in 
control cells. 
 
3.3 Temporal pattern of NA- and CdCl2-induced HSP accumulation.  
In time course studies, immunoblot analysis revealed enhanced HSP30 and 
HSP70 levels from 8 to 24 h of exposure to 30 µM NA (Fig. 6).  A significant increase 
(p<0.05) in HSP30 and HSP70 accumulation was detected after 8 h exposure and 
accumulation increased up to 24 h.  A6 cells treated with 200 µM CdCl2 showed a 
gradual increase in the relative accumulation of HSP30 and HSP70 from 10 to 24 h (Fig. 
7).  Significant increases in HSP30 and HSP70 accumulation were observed after 10 h 
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Figure 6. Localization of HSP30 accumulation in A6 cells treated with NA.  Cells were 
cultured on glass coverslips and maintained at 22 °C or incubated with 20 or 30 µM NA 
for 16 h.  Actin and nuclei were stained directly with phalloidin conjugated to TRITC 
(red) and DAPI (blue), respectively. HSP30 was indirectly detected with an anti-HSP30 
antibody and a secondary antibody conjugated to Alexa-488 (green). The 20 µM white 
scale bars are indicated at the bottom right section of each panel. These data are 
representative of three separate experiments.
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Figure 7. Localization of HSP30 accumulation in A6 cells treated with CdCl2.  Cells were 
cultured on glass coverslips and maintained at 22 °C or incubated with 100 or 200 µM 
CdCl2 for 18 h.  HSP30 was indirectly detected with an anti-HSP30 antibody and a 
secondary antibody conjugated to Alexa-488 (green).  Actin and nuclei were stained 
directly with phalloidin conjugated to TRITC (red) and DAPI (blue), respectively.  The 
20 µM white scale bars are indicated at the bottom right section of each panel.  These 
data are representative of three separate experiments. 
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Figure 8. A time-dependent increase in HSP30 and HSP70 in A6 cells following NA 
treatments.  A) Cells were maintained at 22 °C (C) or treated with 30 µM NA for time 
periods ranging from 4 to 24 h.  After treatment, cells were harvested and total protein 
was isolated and subjected to immunoblot analysis. B) Densitometric analysis of the 
signal intensity for HSP30 (black) and HSP70 (white) protein bands was performed using 
Image J software.  The data are expressed as a percentage of the maximum band. Vertical 
bars represent the standard error.  The level of significance of the differences between 
samples was calculated by one-way ANOVA with a Tukey’s post-test.  Significant 
differences between control (C) cells and NA treated cells are indicated by * (p<0.05).  
These data are representative of three separate experiments. 
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Figure 9. Time course of CdCl2–induced HSP30 and HSP70 accumulation. Cells were 
maintained at 22°C (C) or treated with 200 µM CdCl2 for periods of time ranging from 4 
to 24 hours. After treatment cells were harvested and total protein was isolated and 
subjected to immunoblot analysis employing anti-Xenopus HSP30, anti-Xenopus HSP70 
and anti-actin polyclonal antibodies.  B) Image J software was used to carry out 
densitometric analysis of HSP30 (black bars) and HSP70 (white bars) bands in the 
western blot images.  The percentage of the maximum signal acquired for each protein 
was used to express results and the standard error is represented by vertical bars.  The 
level of significance of the differences between samples was calculated by one-way 
ANOVA with a Tukey’s post-test. Significant differences between control and cadmium 
chloride treatments are indicated as * (p<0.05).  These results are representative of at 
least three different experiments. 
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exposure.  Maximal HSP30 and HSP70 accumulation was noted after 24 h and 18 h 
incubation with CdCl2, respectively. 
 
3.4 Relative levels of ubiquitinated protein increase with NA and CdCl2 treatment 
 The impact of NA and CdCl2 on proteasome activity in Xenopus laevis A6 cells 
was evaluated initially by examining the relative levels of ubiquitinated protein.  The 
relative levels of ubiquitinated protein in cells was determined by immunoblot analysis 
using an anti-ubiquitin antibody.  An increase in the relative level of ubiquitinated protein 
was observed in cells treated for 16 h with 20 or 30 µM NA in comparison to control 
cells (Fig. 10).  MG132, a known proteasomal inhibitor, was employed in this study as a 
positive control.  Densitometric analysis revealed a 1.6- and 1.7-fold increase in cells 
treated with 20 and 30 µM NA, respectively, compared to control cells.  Time course 
studies showed an increase in the relative levels of ubiquitinated protein in cells treated 
with 30 µM NA from 4 to 24 h in comparison to control cells (Fig. 11).  A 2.5-fold 
increase in the relative levels of ubiquitinated protein was noted after 16 or 24 h NA 
treatment in comparison to control.  Similarly, treatment of cells with CdCl2 also 
increased the relative levels of ubiquitinated protein.  After 18 h treatment with 100 or 
200 µM CdCl2 there was an increase in ubiquitinated protein compared to cells 
maintained at 22 °C.  Treatment with 200 µM CdCl2 resulted in a 2-fold increase in the 
level of ubiquitinated protein as determined by statistical analysis (Fig. 12).  Time course 
studies of the relative levels of ubiquitinated protein following treatment with CdCl2 
showed a slight increase after 4 h treatment with a significant increase in accumulation 
after 10, 18 and 24 h treatment (Fig. 13).  
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Figure 10. NA increased the relative level of ubiquitinated protein in A6 cells. A) Cells 
were maintained at 22 °C, treated with 20 or 30 µM NA for 16 h or treated with 30 µM 
MG132 for 16 h. Total protein was isolated and subjected to immunoblot analysis 
employing a mouse anti-ubiquitin antibody as described in the Materials and methods. B) 
Densitometric analysis was performed on each lane using Image J software. Results are 
expressed as a percentage of the maximal signal acquired. The standard error is 
represented by vertical bars. One-way ANOVA with a Tukey’s post-test was used to 
determine the level of significance of the differences between samples. The symbol * 
represents the significant difference (p<0.05) between control and cells treated with NA. 
These results are representative of at least three separate experiments. 
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Figure 11. Temporal pattern of ubiquitinated protein levels in A6 cells treated with NA. 
A) Cells were maintained at 22 °C or treated with 30 µM NA for 4, 8, 16 or 24 h. Total 
protein was isolated and subjected to immunoblot analysis. B) Image J software was used 
to perform densitometric analysis of the signal intensity for each lane of the 
immunoblots. The data are expressed as a percentage of the lane with the maximum 
signal while vertical bars represent the standard error. The level of significance of the 
differences between samples was calculated by one-way ANOVA with a Tukey’s post-
test. Significant differences between control (C) and cells exposed to 30 µM NA are 
indicated as * (p<0.05). These data are representative of three separate experiments. 
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Figure 12. Treatment with CdCl2 increases the relative levels of ubiquitinated protein. A) 
Cells were maintained at 22 °C (C) or treated with 100 or 200 µM CdCl2 for 18 h. Total 
protein was isolated and subjected to immunoblot analysis. B) Densitometric analysis of 
the signal intensity for the protein of the immunoblot was performed using Image J 
software. The data are expressed as a percentage of the lane with the maximum signal.  
Vertical error bars represent the standard error. The level of significance of the 
differences between samples was calculated by one-way ANOVA with a Tukey’s post-
test. Significant differences between control and cells exposed to cadmium chloride are 
indicated as * (p<0.05). These data are representative of three separate experiments. 
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Figure 13. Temporal examination of ubiquitinated protein levels of A6 cells treated with 
CdCl2.  A) Cells were maintained at 22 °C or treated with 200 µM CdCl2 for 4, 10, 18 or 
24 h.  After treatment, total protein was isolated and subjected to immunoblot analysis. B) 
Densitometric analysis was performed using Image J software to determine the signal 
intensity for each lane of the immunoblots. The data are expressed as a percentage of the 
lane with the maximum signal while vertical bars represent the standard error.  The level 
of significance of the differences between samples was calculated by one-way ANOVA 
with a Tukey’s post-test. Significant differences between control (C) and cells exposed to 
200 µM CdCl2 are indicated as * (p<0.05). These data are representative of three separate 
experiments.
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3.5. NA and CdCl2 decrease chymotrypsin(CT)-like activity in Xenopus A6 cells.  
 Another method to examine the impact of NA and CdCl2 on proteasome activity 
in A6 cells involved a measurement of the relative levels of CT-like activity.  CT-like 
activity is a component of the 26S proteasome.  CT-like activity, as determined by means 
of a cell-based assay, decreased approximately 40% in A6 cells treated with 20 or 30 µM 
NA for 16 h when compared to control cells (Fig. 14).  In cells treated with 100 or 200 
µM CdCl2 for 18 h resulted in 40% and 70% decrease, respectively, in CT-like activity 
compared to control (Fig. 15).   
 
3.6 Involvement of HSF1 activation in NA- and CdCl2-induced HSP and 
ubiquitinated protein accumulation 
In order to determine any possible association between heat shock protein 
accumulation and proteasome activity a HSF1 inhibitor, KNK437, was employed.  
Previously, our laboratory demonstrated that KNK437 pretreatment inhibited both heat 
shock and chemical stress-induced hsp gene expression in A6 cells (Manwell and 
Heikkila, 2007; Voyer and Heikkila, 2008; Young et al., 2009).  As shown in Figures 16 
and 17, when cells were pretreated with KNK437 prior to NA or CdCl2, there was 
extensive inhibition of HSP30 and HSP70 accumulation.  Subsequent analysis 
demonstrated that KNK437 caused 90% and 70% inhibition of 20 and 30 µM NA-
induced and 100% inhibition of CdCl2-induced HSP30 and HSP70 accumulation.  
Further examination of the relationship of HSP accumulation and proteasome activity 
looked at the relative levels of ubiquitinated protein after pretreatment with KNK437.  
Treatment with KNK437 alone had no significant effect of the relative levels of
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Figure 14. Effect of NA on chymotrypsin-like activity of A6 cells. Cells were maintained 
at 22 °C (C) or treated with 20 or 30 µM NA for 16 h. After treatment cells were 
suspended in L-15 media and chymotrypsin-like activity was determined as described in 
the Materials & methods. The CT-like activity was measured and expressed as a 
percentage of control. The level of significance of the differences between samples was 
calculated by one-way ANOVA and a Tukey’s post-test. Significant differences between 
control cells and cells treated with NA indicated as * (p<0.05). These data are 
representative of three separate experiments. 
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Figure 15. Inhibition of chymotrypsin-like activity in A6 cells treated with CdCl2. Cells 
were maintained at 22 °C (C) or treated with 100 or 200 µM CdCl2 for 18 h. The relative 
levels of chymotrypsin-like activity was determined and expressed as a percentage of 
control. The level of significance of the differences between samples was calculated by 
one-way ANOVA with a Tukey’s post-test. Significant differences between control cells 
and A6 cells treated with CdCl2 are indicated as * (p<0.05). These results were derived 
from three different experiments. 
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Figure 16. Effect of KNK437 on NA-induced HSP30 and HSP70 accumulation. Cells 
were maintained at 22 °C (C) or treated with 20 or 30 µM NA with (+) or without (-) a    
2 h pre-treatment with 100 µM KNK437.  After treatment cells were harvested and total 
protein was isolated and subjected to immunoblot analysis.  B) Image J software was 
used to carry out densitometric analysis of HSP30 (black) and HSP70 (white) bands in 
the western blot images. Results are expressed as a percentage of the signal acquired 
without pretreatment with KNK437 for each protein.  Vertical error bars represent the 
standard error.  The level of significance of the differences between samples with and 
without pretreatment with KNK437 was calculated by one-way ANOVA with a Tukey’s 
post-test. Significant differences between cells with or without pretreatment with 
KNK437 are indicated as * (p<0.05).  These results are representative of at least three 
different experiments. 
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Figure 17. Effect of KNK437 on CdCl2-induced HSP30 and HSP70 accumulation. Cells 
were maintained at 22 °C or treated with 100 or 200 µM CdCl2 with (+) or without (-) a  
2 h pre-treatment with 100 µM KNK437 at 22 °C. Total protein was isolated and 
subjected to immunoblot analysis. B) Densitometric analysis of HSP30 (black) and 
HSP70 (white) bands in the western blot images was carried out using Image J software.  
Results are expressed as a percentage of the signal acquired without pretreatment with 
KNK437 for each protein. Vertical error bars represent the standard error. The level of 
significance of the differences between samples with and without pretreatment with 
KNK437 was calculated by one-way ANOVA with a Tukey’s post-test. Significant 
differences between cells with or without pretreatment with KNK437 are indicated as * 
(p<0.05). These results are representative of at least 3 different experiments. 
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ubiquitinated protein.  A 2 h pretreatment with KNK437 followed by 16 h NA reduced 
the levels of ubquitinated protein.  Densitometric analysis revealed that ubiquitinated 
protein levels decreased by 25% and 15% when pretreated with KNK437 followed by 20 
and 30 µM NA, respectively, as shown in figure 18.  Figure 19 shows the effect of 
pretreatment with KNK437 prior to incubation with CdCl2 on the relative levels of 
ubiquitinated proteins.  Significant decreases of 25% and 40% were seen in A6 cells 
pretreated by KNK437 followed by 100 or 200 µM CdCl2, respectively, for 18 h.  
Pretreatment with KNK437 also had no effect on cellular morphology, which is in 
agreement with results found previously in our laboratory (Voyer and Heikkila, 2008). 
 
3.7 KNK437 had no effect on NA- or CdCl2-induced inhibition of CT-like activity.   
In order to examine the effect of inhibiting HSP accumulation on proteasome 
activity, A6 cells were pretreated with KNK437 prior to NA or CdCl2 and CT-like 
activity was measured.  KNK437, alone, had no effect on CT-like activity compared to 
control cells.  As previously mentioned treatment of A6 cells with NA decreased CT-like 
activity by approximately 40% compared to control cells.  A 2 h pretreatment with 
KNK437 followed by 16 h NA resulted in no significant change between cells pretreated 
compared to cells without a pretreatment with KNK437 (Figure 20).  In A6 cells treated 
with 100 µM or 200 µM CdCl2 there was a decrease of approximately a 35% and 75%, 
respectively, compared to control cells.  In cells pretreated with KNK437 prior to CdCl2 
there was no significant difference in the CT-like activity of cells compared to cells 
treated with CdCl2 without pretreatment (Figure 21).  
	   	  62	  
Figure 18. KNK437 decreases the relative level of ubiquitinated protein. A) Cells were 
maintained at 22 °C or treated with 20 or 30 µM NA with (+) or without (-) a 2 h 
pretreatment with 100 µM KNK437. After treatment cells were harvested and total 
protein was isolated and subjected to immunoblot analysis.  B) Densitometric analysis of 
ubquitinated protein was performed on immunoblots using Image J software. Results are 
expressed as a percentage of NA treatment without KNK437 pretreatment. Vertical bars 
represent the standard error. The level of significance of the differences between samples 
was calculated by one-way ANOVA with a Tukey’s post-test. Significant difference 
between cells with or without pretreatment is represented by * (p<0.05) or ∇ (p<0.15). 
These results are representative of 3 separate experiments.
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Figure 19. The relative levels of ubiquitinated protein in cells pretreated with KNK437.  
A) Cells were maintained at 22 °C or treated with 100 or 200 µM CdCl2 with (+) or 
without (-) a 2 h pretreatment with 100 µM KNK437. Total protein was isolated and 
subjected to immunoblot analysis.  B) Image J software was used to carry out 
densitometric analysis of ubiquitinated protein on immunoblots. Results are expressed as 
a percentage of CdCl2 treatment without KNK437 pretreatment. Vertical bars represent 
the standard error. The level of significance of the differences between samples was 
calculated by one-way ANOVA with a Tukey’s post-test. Significant difference between 
cells with or without pretreatment with KNK437 is represented by * (p<0.05).  These 
results are representative of 3 separate experiments. 
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Figure 20. Pretreatment with KNK437 had no effect on NA-induced changes in CT-like 
activity.  Cells were maintained at 22 °C or treated with 20 or 30 µM NA with or without 
a 2 h pretreatment with 100 µM KNK437.  The CT-like activity was measured and 
expressed as a percentage of control. The level of significance of the differences between 
samples with or without pretreatment with KNK437 was calculated by one-way ANOVA 
with a Tukey’s post-test.  No significant difference was noted between samples with and 
without pretreatment with KNK437.  These results are representative of 3 separate 
experiments. 
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Figure 21.  CT-like activity of A6 cells treated with CdCl2 with or without pretreatment 
with KNK437. Cells were maintained at 22 °C or treated with 100 or 200 µM CdCl2 with 
or without a 2 h pretreatment with 100 µM KNK437.  The CT-like activity was measured 
and expressed as a percentage of control. The level of significance of the differences 
between samples with or without pretreatment with KNK437 was calculated by one-way 
ANOVA with a Tukey’s post-test.  No significant difference was observed between 
samples with and without pretreatment with KNK437.  These results are representative of 
3 separate experiments. 
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4. Discussion 
 
The present study has shown that NA and CdCl2 can induce HSP accumulation 
and inhibit proteasomal activity in Xenopus laevis A6 kidney epithelial cells.  For 
example, treatment of A6 cells with 20 or 30 µM NA significantly increased HSP30 and 
HSP70 accumulation compared to control.  Furthermore, the relative levels of HSP30 and 
HSP70 increased in a time-dependent manner from 8 to 24 h when treated with 30 µM 
NA or 200 µM CdCl2.  These findings are in agreement with earlier studies showing that 
treatment of A6 cells with NA or CdCl2 induced HSP30 and HSP70 accumulation (Ohan 
et al., 1998; Phang et al., 1999; Fernando and Heikkila, 2000; Gellalchew and Heikkila, 
2005; Young et al., 2009; Woolfson and Heikkila, 2009).  In other systems, arsenite-
treated rat astrocytes or human bladder urothelial cells showed significantly higher levels 
of HSPs compared to control cells (Fauconneau et al., 2002; Rossi et al., 2002).  Also, in 
cadmium treated rat kidney NRK-52E cells and zebrafish embryos increases in HSP 
levels were reported (Madden et al., 2002; Hallare et al., 2005).   
Immunocytochemistry and LSCM were employed to verify the immunoblot 
analyses and to examine the localization of HSP30 in A6 cells treated with NA or CdCl2.  
Cells exposed to NA (20 and 30 µM) or CdCl2 (100 and 200 µM) displayed enhanced 
accumulation of HSP30 primarily in the cytoplasm in a punctate pattern.  The granular 
pattern of stress-induced HSP30 accumulation may be caused by the formation of 
multimeric structures which are required for sHSP function (Ohan et al., 1998; MacRae, 
2000; Van Montfort et al., 2001). The actin cytoskeleton has been used an indicator of 
cellular viability and health (Wiegant et al., 1987; Ohtsuka et al., 1993). The current 
study showed that treatment of A6 cells with NA or CdCl2 resulted in the presence of 
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actin aggregates which suggests disruption of the actin cytoskeleton.  These results are 
comparable to those found previously in our laboratory (Gellalchew and Heikkila, 2005; 
Voyer and Heikkila, 2008; Woolfson and Heikkila, 2009).   
The exact mechanism of activation of hsp gene expression in response to NA or 
CdCl2 in A6 cells is not known at this time.  However, The regulation of NA- or CdCl2-
induced HSP accumulation in Xenopus occurs, at least in part, at the level of transcription 
since both of these stressors can induce HSF1-HSE binding as detected by gel mobility 
shift analysis (Gordon et al., 1997).  Also, our laboratory recently determined in studies 
employing KNK437, an inhibitor of HSP accumulation, that hsp gene expression in 
Xenopus cells by NA or CdCl2 is likely controlled, at least in part, by the activation of 
HSF1 (Voyer and Heikkila, 2008).  Under stress conditions, unfolded or damaged protein 
is thought to be a signal for the activation of hsp gene expression (Voellmy et al., 2004).  
Increased concentrations of non-native proteins can result in aggregate formation, which 
is detrimental to cell function (Hartl 1996; Lee and Goldberg, 1998; Hartl and Hayer-
Hartl, 2009).  It has been reported that arsenite toxicity may be caused by a decrease in 
sulfhydryl groups and by generating reactive oxygen species which increase the levels of 
protein carbonyls (Chen et al., 1998; Liu et al., 2001; Del Razo et al., 2001; Samuel et al., 
2005).  Also, it was suggested that cadmium substitutes for zinc in proteins and reacts 
with thiol groups within cells to induce the accumulation of abnormal proteins (Waisberg 
et al., 2003; Galazyn-Sidorczuk et al., 2009).  Therefore, treatment of cells with NA or 
CdCl2 may lead to an increase in the intracellular level of damaged proteins which 
initiates the activation of HSF1 leading to hsp gene expression.   
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In Xenopus laevis A6 cells, like other eukaryotic systems, the ubiquitin-
proteasome system (UPS) is the primary degradation pathway for misfolded or damaged 
proteins (Lee and Goldberg, 1998; Malik et al., 2001).  Previous studies have shown that 
inhibiting the activity of the proteasome leads to the accumulation of damaged or 
unfolded proteins within cells which are targeted for degradation by the addition of 
polyubiquitin chains (Bush et al., 1997; Lee and Goldberg, 1998; Malik et al., 2001; Liao 
et al., 2006).  The 26S proteasome is responsible for enzymatic degradation of ubiquitin 
tagged proteins.  In other studies, an indicator of proteasome inhibition is an increase in 
the relative levels of ubiquitinated protein (Mimnaugh et al., 1997; Melikova et al., 
2006).  In Xenopus A6 cells incubation with 20 or 30 µM NA increased the relative levels 
of ubiquitinated protein by 1.6- and 1.7-fold, respectively.  Also, treatment of A6 cells 
with 100 or 200 µM CdCl2 increased the relative levels of ubiquitinated protein by 0.5- 
and 2-fold, respectively.  In a survey of the scientific literature, the effect of NA on 
proteasome activity has been examined only in mammalian cells (Tsou et al., 2005; 
Medina-Diaz et al., 2009; Kirkpatrick, 2003).  For example, an increase in ubiquitinated 
protein was shown in mouse CYP3A4 cells following treatment with NA or other arsenite 
metabolites (Medina-Diaz et al., 2009).  Also, the relative levels of ubiquitinated protein 
in rabbit renal-cortical slices and human embryonic kidney cells (HEK293) increased 
following treatment with arsenite (Kirkpatick et al., 2003).  Furthermore, Kirkpatrick et 
al. (2003) demonstrated that treatment with arsenite had no effect on the activity of the 
ubiquitin-conjugating enzymes suggesting that an increase in ubiquitinated protein results 
from impaired degradation of targeted proteins.  Finally, CdCl2-induced increases in 
ubiquitinated protein levels has been demonstrated only in mammalian cells with the 
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exception of studies employing two different marine bivalves, mussels and clams 
(Thevenod and Friedmann, 1999; Figueiredo-Pereira and Cohen, 1999; Othumpangat et 
al., 2005; McDonagh and Sheegan, 2006; Chora et al., 2008; Li et al., 2008; Yu et al., 
2008; McDonagh, 2009; Yu et al., 2011).   
In order to further examine the effect of NA and CdCl2 agents on proteasome 
activity in A6 cells, a cell-based assay was used to examine chymotrypsin (CT)-like 
activity, which is a component of the 26S proteasome.  The present study revealed that 
treatment with 20 or 30 µM NA decreased CT-like activity in A6 cells by 40% compared 
to control cells.  A6 cells treated with 100 or 200 µM CdCl2 showed a decrease in CT-
like activity of 40% and 70%, respectively.  Taken together, the NA- or CdCl2-induced 
accumulation of ubiquitinated protein and the decrease in chymotrypsin-like activity was 
suggestive of NA- and CdCl2-induced proteasomal inhibition in Xenopus laevis A6 cells.  
In other studies which examined only mammalian systems, rabbit renal-cortical slices 
treated with 10 µM arsenite for 24 h displayed a 40% decrease in CT-like activity 
compared to control (Kirkpatrick et al., 2003).  Also, in HEK293 cells a 15% decrease in 
CT-like activity was observed after 24 h treatment with 10 µM arsenite in comparison to 
control cells (Kirkpatrick et al., 2003).  Finally, in rat sertoli cells, treatment with 10 or 20 
µM cadmium resulted in no significant changes in CT-like activity compared to control 
(Yu et al., 2008).  While the exact mechanism of NA or CdCl2-induced proteasome 
inhibition in A6 cells is not known at this time, it is possible that these agents may 
damage key proteins involved in protein ubiquitination or the normal functioning of the 
proteasome complex (Rea et al., 2003; Su et al., 2006; Yu et al., 2010). 
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As previously mentioned it is likely that the induction of hsp gene expression in 
Xenopus by NA or CdCl2 involves the activation of HSF1 and binding to the HSE 
(Ovsenek and Heikkila, 1990).  To examine a possible association between NA- or 
CdCl2-induced HSP accumulation and proteasomal activity an HSF1 inhibitor, KNK437, 
was employed. KNK437 is a benzylidene lactam compound which has been shown to 
inhibit HSF1 activation (Yokota et al., 2000).  Treatment of human tumour cells with 
KNK437 inhibited the acquisition of thermotolerance and prevented their protection from 
heat-induced apoptosis (Yokota et al., 2000; Sahin et al., 2011).  Previously, our 
laboratory demonstrated that KNK437 was capable of inhibiting heat-induced hsp30, 
hsp47 and hsp70 mRNA and HSP30 and HSP70 protein accumulation in A6 cells 
(Manwell & Heikkila, 2007; Voyer and Heikkila, 2008).  The present study examined the 
effect of KNK437 pretreatment on NA- and CdCl2-induced HSP accumulation and the 
inhibition of proteasomal activity.  A 2 h pretreatment with KNK437 followed by 
incubation with NA or CdCl2 significantly reduced both HSP30 and HSP70 accumulation 
in A6 cells which confirmed previous studies in our laboratory (Voyer and Heikkila, 
2008).  While KNK437, alone, had no significant effect on the levels of ubiquitinated 
protein, pretreatment with KNK437 induced a 25% and 20% reduction in the relative 
levels of ubiquitinated protein in cells treated with 20 and 30 µM NA, respectively, 
compared to A6 cells treated with NA and no pretreatment.  In A6 cells treated with 100 
and 200 µM CdCl2, pretreatment with KNK437 reduced the ubiquitinated protein levels 
by 30% and 40%, respectively.  However, KNK437 pretreatment had no effect on the 
NA- or CdCl2-induced inhibition of CT-like activity.  These results suggest that inhibiting 
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HSP accumulation by KNK437 inhibited the ubiquitination of damaged proteins induced 
by NA or CdCl2.   
Recent studies have shown that HSP70 can have an effect on client protein 
turnover by promoting protein ubiquitination (Pratt et al., 2010).  Ubiquitination involves 
three sequential steps catalyzed by activating (E1), conjugating (E2) and ligase (E3) 
enzymes.  In previous studies it was suggested that HSP70 is the main substrate 
recognition factor of the carboxyl terminus of Hsc70-interacting protein (CHIP), an E3 
ubiquitin ligase (Esser et al., 2004).  CHIP binds to HSC70 and HSP70 through its 
amino-terminal tetratricopeptide domain and binds to E2 conjugating enzymes by the 
carboxy-terminal U-box domain.  Peng et al. (2004) reported that in the absence of 
chaperones there is a basal level of polyubiquitination, however the addition of purified 
HSP70 and HSP40 to the CHIP-containing reaction enhanced the ubiquitination of 
protein.  Also, the cystic fibrosis transmembrane conductance receptor undergoes 
degradation that is both CHIP and HSP70 dependent (Meacham et al., 2001).  Finally, 
luciferase undergoes CHIP-dependent ubiquitination when it is misfolded and bound to 
HSP70 (Murata et al., 2001).  These studies indicate that CHIP preferentially 
ubiquitinates HSP70-bound substrates.  However, it is also possible that inhibiting 
HSP70 accumulation (and possibly other HSPs) could have a negative effect on the 
mechanism by which ubiquitination occurs.   A simplified model of the possible 
interaction of HSP70 and CHIP during ubiquitination is shown in Figure 20. Stressful 
stimuli cause native proteins in the cell to unfold, which recruits molecular chaperones 
such as HSP70 to prevent aggregation of unfolded proteins.  CHIP targets HSP70 bound 
substrates for ubiquitination and binds to HSP70 and E2 conjugating enzymes which 
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Figure 22.  Proposed model of HSP70-dependent ubiqutination by CHIP.  (1) Stressful 
stimuli cause native proteins in the cell to unfold which activates HSF1.  (2) This recruits 
HSP70 and other molecular chaperones to prevent aggregation of unfolded proteins.     
(3) CHIP, an E3 ubiquitin ligase, targets HSP70 bound substrates for ubiquitination and 
binds to HSP70 and E2 conjugating enzymes (4).  This results in polyubiquitinated 
proteins that are destined for degradation (5).  KNK437 inhibits HSF1 activation which 
decreases the amount of stress-inducible HSPs and the number of HSP70 bound 
substrates that can undergo ubiquitination (6).
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results in polyubiquitinated proteins destined for degradation.  A sHSP, HSP27, was 
shown to interact with polyubiquitin chains and suggested to be an activator of the 
ubiquitin-proteasome system. Parcellier et al. (2003) demonstrated that HSP27 may be 
involved in the ubiquitination of several cellular proteins, but the mechanism of how 
these proteins are selected for HSP27-mediated ubiquitination remains to be determined. 
Given this latter study, it is possible that the Xenopus sHSP, HSP30, may play a similar 
role in protein ubiquitination. 
An overview of how NA and CdCl2 could induce hsp gene expression through 
increased levels of unfolded protein and/or ubiquitinated damaged protein is shown in  
Figure 21.  Exposure of cells to NA or CdCl2 causes an increase in unfolded protein and 
inhibits proteasome activity which results in an increase in ubiquitinated damaged 
protein.  These events result in the recruitment of HSPs which are bound to HSF1 to bind 
to unfolded protein or damaged protein destined for ubiquitination.  This results in HSF1 
activation and transcription of stress-inducible hsps.  Newly synthesized stress-inducible 
HSPs bind to the unfolded protein in the cell to inhibit aggregation as well as to aid in 
CHIP-dependent ubiquitination of damaged protein. 
In summary, this study has shown that NA and CdCl2 induce HSP30 and HSP70 
accumulation in Xenopus cells.  In addition, this study has demonstrated for the first time, 
in poikilothermic vertebrates, that NA and CdCl2 increased the accumulation of 
ubiquitinated protein and inhibited chymotrypsin-like activity.  Also, inhibiting stress-
induced HSP accumulation using KNK437 decreased the relative levels of ubiquitinated 
protein resulting from NA or CdCl2 treatment.  Furthermore, this study showed that the 
inhibition of chymotrypsin-like activity by treatment with NA or CdCl2 was not affected
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Figure 23. Overview of the effect of NA and CdCl2 on proteasome activity and hsp gene 
expression.  NA and CdCl2 increase unfolded protein (1) and inhibit proteasomal activity 
which results in a build up of ubiquitinated protein (2).  This recruits HSP90 to unfolded 
protein or for CHIP-dependent ubiquitination of damaged protein leaving HSF1 as a free 
monomer (3).  HSF1 trimerizes  (4) and translocates to the nucleus binding to the HSE of 
hsp genes initiating transcription of stress-inducible hsps (5).  Newly synthesized HSPs 
bind to the unfolded protein in the cell or associate with CHIP to ubiquitinate damaged 
protein destined for degradation.
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by KNK437 pretreatment. The finding that both NA and CdCl2 can induce proteasome 
inhibition in Xenopus A6 cells as indicated by enhanced protein ubiquitination and 
inhibition of CT-like activity is of importance given that both of these agents are 
widespread environmental pollutants.  Also, NA and CdCl2 can have teratogenic and 
carcinogenic effects in humans and other organisms (Del Razo et al., 2001; Waisberg et 
al., 2003).  Given that CdCl2 and NA are often found as water contaminants, aquatic 
organisms, such as amphibians and fish, are very susceptible to their deleterious effects.  
In the future it will be of interest to determine if other aquatic species undergo 
proteasomal inhibition after exposure to NA or CdCl2 and whether proteasome activity 
can be used as a molecular biomarker for environmental contamination.   Additionally, 
understanding the effect of various stressors on proteasome function and hsp gene 
expression is of importance due to the potential therapeutic role of HSPs in various 
human diseases.  Proteasome dysfunction and hsp gene expression have been implicated 
in numerous disease states including Alzheimer’s disease (Morimoto, 2008).    
Given the findings of this study, further analysis of the relationship between NA- 
and CdCl2-induced proteasome inhibition and the accumulation of HSPs is required.  
Therefore, future studies could look at the specific-involvement of HSP70 and HSP30 in 
ubiquitination.  KNK437 is a broad inhibitor of hsp gene expression.  Studies involving 
siRNA can elicit highly sequence-specific gene silencing.  Transfection with siRNA 
could inhibit specific expression of HSPs to further examine the role of HSP70 and 
HSP30 in ubiquitination.  In pancreatic cancer cells, HSP70 downregulation by siRNA 
resulted in the induction of apoptosis (Dudeja et al., 2009).  In rat brain astrocytes treated 
with MG132, downregulation of HSP25 by siRNA caused cells to be more sensitive to 
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stress induced by proteasomal inhibition, impaired microfilament organization and 
resulted in cell death (Goldbaum et al., 2009).  Other studies in Xenopus A6 cells could 
employ co-immunoprecipitation assays in order to examine the relationship between 
CHIP, ubiquitinated protein, HSP70 and HSP30.  For example, in HEK293 cells CHIP 
and HSP70 were shown to bind heat-stressed luciferase, as determined by co-
immunoprecipitation (Rosser et al., 2007).  
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